| WKN: | A1W1SJ |
| ISIN: | US29664W1053 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Esperion Therapeutics-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 21. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2017 | 11,69 | 54,71 | 368,01% |
| 2 | 2025 | 2,12 | 3,20 | 50,94% |
| 3 | 2019 | 37,58 | 52,38 | 39,38% |
| 4 | 2022 | 4,18 | 5,42 | 29,67% |
| 5 | 2024 | 2,69 | 2,12 | -21,19% |
| 6 | 2015 | 28,96 | 20,22 | -30,18% |
| 7 | 2018 | 54,71 | 37,58 | -31,31% |
| 8 | 2026 | 3,20 | 2,19 | -31,56% |
| 9 | 2016 | 20,22 | 11,69 | -42,19% |
| 10 | 2023 | 5,42 | 2,69 | -50,37% |
| 11 | 2020 | 52,38 | 21,86 | -58,27% |
| 12 | 2021 | 21,86 | 4,18 | -80,88% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2021 | 21,86 | 4,18 | -80,88% |
| 2 | 2020 | 52,38 | 21,86 | -58,27% |
| 3 | 2023 | 5,42 | 2,69 | -50,37% |
| 4 | 2016 | 20,22 | 11,69 | -42,19% |
| 5 | 2026 | 3,20 | 2,19 | -31,56% |
| 6 | 2018 | 54,71 | 37,58 | -31,31% |
| 7 | 2015 | 28,96 | 20,22 | -30,18% |
| 8 | 2024 | 2,69 | 2,12 | -21,19% |
| 9 | 2022 | 4,18 | 5,42 | 29,67% |
| 10 | 2019 | 37,58 | 52,38 | 39,38% |
| 11 | 2025 | 2,12 | 3,20 | 50,94% |
| 12 | 2017 | 11,69 | 54,71 | 368,01% |